Latest GM & Biosafety Resources
28 August 2025
CVAB welcomes Burkina Faso’s decision to terminate “Target Malaria” project
Press Release Ouagadougou, August 22, 2025 Target Malaria is a research consortium led by Imperial College London, which receives core funding from the Bill and Melinda Gates Foundation to apparently eradicate malaria in Africa. The first phase of its project in Burkina Faso has been a dismal failure, involving the release of GM mosquitoes. We […]
READ28 April 2022
The financialisation of malaria in Africa: Burkina Faso, rogue capital & GM /gene drive mosquitoes
(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]
READ29 May 2020
Profiteering from health and ecological crisis in Africa: The Target Malaria project and new risky GE technologies
Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]
READ28 May 2020
GM Fungi to kill Mosquitoes: Illegal experiments in Burkina Faso?
(Cliquez ici pour le français) Conducted silently and out of the public eye, a three-year experiment involving a new and potentially unsafe and risky genetically modified (GM) fungus to kill mosquitoes was performed in the village of Soumousso in Burkina Faso in 2019. When the study was published in a US scientific journal in May […]
READ13 May 2019
Gene drive organisms: What Africa should know about actors, motives and threats to biodiversity and food systems
The African Centre for Biodiversity (ACB) has produced a briefing paper in regard to a new and controversial genetic engineering (GE) technology to produce gene drive organisms (GDOs). These GDOs have been specifically designed to spread an engineered, ‘modified’ genetic trait such as sterility, with the potential to eradicate entire wildlife populations and even species. […]
READ30 April 2019
Oxitec’s failed GM mosquito releases worldwide: Forewarnings for Africa and the Target Malaria project
A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil. In a public relations whitewash, Oxitec has repeatedly claimed that the experiments successfully wiped out nearly 90% of the Aedes aegypti mosquito population, which is one of the […]
READ9 November 2018
Release of risky GM mosquitoes in Burkina Faso highly unethical
Press Release issued by African Centre for Biodiversity, Third World Network and GeneWatch UK Johannesburg, 9 November 2018 Release of risky GM mosquitoes in Burkina Faso highly unethical Risky genetically modified (GM) “male-sterile” mosquitoes are due to be released in the very near future, in Burkina Faso by the Target Malaria research consortium. However, Target […]
READ20 June 2018
What Does Synthetic Biology Mean for Africa? – An Africa Regional Briefing publication produced by ETC, Third Word Network and The African Centre for Biodiversity
Huge technical advances in molecular biology and big data biology are leading us towards a ‘forth industrial revolution’ with the ongoing development of novel genetic engineering techniques being reviewed by the UN Conventions for Biological Diversity, under the term ‘synthetic biology’. Such techniques are widening the scope and extent to which organisms can be modified, […]
READ9 February 2018
Press Release: No benefit to imminent release of risky GM mosquitoes in Burkina Faso
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release. The project is set to apply for a permit to make an open release of 10,000 GM Anopheles gambiae […]
READ8 February 2018
Briefing Paper: GM Mosquitoes in Burkina Faso
In this briefing paper ACB, TWN and GeneWatch UK discuss that genetically modified (GM) mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016. They are currently in “contained use” facilities in Bobo-Dioulasso, and are being used in experiments by a research consortium called Target Malaria. However, these GM mosquitoes are […]
READ18 October 2017
The GMO crisis in Swaziland
Swaziland is under enormous pressure to introduce genetically modified organisms (GMOs) into the country’s farming system. This pressure is coming not only from Monsanto but also from farmers and some sections of the public who have been fed a great deal of misinformation and hype by the pro-biotech machinery. The farmers, acting on incomplete and […]
READ25 April 2017
Objection to commercial release of MON87460 X NK603 X MON89034 (triple stacked involving drought tolerant maize trait)
In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event. Drought tolerance is a highly complex genetic trait that cannot be addressed by single gene insertions, as shown by the lack of data backing up the applicant’s claim that this GM variety shows “improvements […]
READ